For the year ending 2025-12-31, CNTB has $56,075K in assets. $14,095K in debts. $38,345K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 38,345 | |||
| Short-term investments | 5,997 | |||
| Accounts receivable, net | 13 | |||
| Prepaid expenses and other current assets | 6,574 | |||
| Total current assets | 50,929 | |||
| Property and equipment, net | 3,808 | |||
| Right-of-use lease assets, net | 647 | |||
| Intangible assets, net | 45 | |||
| Other assets | 646 | |||
| Total assets | 56,075 | |||
| Accounts payable | 1,964 | |||
| Accrued liabilities | 11,160 | |||
| Contract liabilities | 167 | |||
| Current lease liabilities | 322 | |||
| Total current liabilities | 13,613 | |||
| Non-current lease liabilities | 368 | |||
| Other non-current liabilities | 114 | |||
| Total liabilities | 14,095 | |||
| Ordinary shares, 0.000174 par value 400,000,000 shares authorized 56,442,308 and 55,349,208 shares issued and outstanding at december 31, 2025 and 2024, respectively | 10 | |||
| Additional paid-in capital | 444,176 | |||
| Accumulated other comprehensive loss | -1,191 | |||
| Treasury shares | 180 | |||
| Accumulated deficit | -400,835 | |||
| Total shareholders' equity | 41,980 | |||
| Total liabilities and shareholders' equity | 56,075 | |||
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)